Jiao Hong,CNDA Commissioner meets UNAIDS Executive Director Michel Sidibe (CFDA)
India
Government may scrap trials for some IVD devices (Livemint)
APAC Biotech and Diakonos collaborate on immunotherapy technology for India (The Pharma Letter) (Press)
Astrazeneca Pharma sweetens after securing permission (Business Standard)
Australia
Three babies and young adult given donor tissue from cancer patient (The Guardian)
Inaugural Industry Forum on Good Manufacturing Practice (GMP) (TGA)
Metronidazole intravenous infusion 500 mg/100 mL bag (TGA)
Canada
Proposed Amendments to Regulations Define Health Care Institutions’ Pharmaceutical and Medical Device Adverse Event Reporting Obligations (Lexology-$)
List of Drugs for an Urgent Public Health Need (Health Canada)
General Health & Other Interesting Articles
Many psychiatric conditions have the same genes in common (New Scientist)
Researchers Just Printed Sensors Onto Gummi Candies (Forbes)
Lifestyle changes can help obese women improve fertility (Reuters)
Targeting cancer cells' escape vehicles to stop tumor metastasis (Fierce)
Will launching plants into orbit yield new medicines? (STAT)
Regulatory Reconnaissance is our daily intelligence briefing for the regulatory affairs space, bringing you the top regulatory news stories from around the globe. Each weekday morning, we aim to bring you the latest highlights of new approvals, meetings, legal and political developments, regulations and guidance, and the latest trends with the potential to impact regulatory affairs professionals and the industry in which they work.
Need to contact the editor of Regulatory Reconnaissance? Email us at [email protected].
A story's inclusion in Regulatory Reconnaissance does not imply endorsement by Regulatory Focus or RAPS.
We have completed our migration to a new platform and are pleased to introduce the updated site.
What to expect: If you have an existing login, please RESET YOUR PASSWORD before signing in. After you log in for the first time, you will be prompted to confirm your profile preferences, which will be used to personalize content.
We encourage you to explore the new website and visit your updated My RAPS page. If you need assistance, please review our FAQ page.